Alopecia

Posts

Hair Growth Cap ZeroT

Hair Growth Cap ZeroT

Hair Growth Cap ZeroT Is On Its Way to Raise Six Figures on Indiegogo

ZeroT Cap is ZEROi LAB’s third crowdfunding hat product and is their most innovative yet. It is a Low-level Light Therapy (LLLT) cap that makes professional hair treatment accessible to the average consumer. It has received a warm welcome from the global crowdfunding community for being a one-of-a-kind product offered at an affordable price. This is also ZEROi LAB’s third crowdfunding project

After reaching its Indiegogo funding goal in just 12 hours, the product went on to be featured as a Team Favorite by Indiegogo’s team as well as featured by many backer-community platforms like Kickbooster and BackerLand. With the campaign nearing $50,000 at its halfway point, it’s well on pace to reach six figures by the end.

ZeroT has three 20-minute modes of care—red light, blue light, and dual mode. The red light (650nm) reaches deep into the scalp to stimulate nutrient flow to the hair follicles while blue light (405nm) eliminates unnecessary oils and germs from the scalp’s surface. Dual mode allows total care with ten minutes of red light followed by ten minutes of blue light.

ZeroT also has three intensity levels, totalling at nine treatment options.

Despite the cap being wireless and flexible, making it more convenient to wear on the go, it is listed at a fraction of the price of other hair growth helmets on the market. Most caps of similar hair treatment are priced at $1,000 while ZeroT Cap’s Early Bird reward price is $140.

“In order to see an actual difference in your hair, you need to uphold a regular care routine,” said ZEROi LAB CEO Taekyeong Oh. “The goal of ZeroT Cap is to present an affordable and convenient solution to hair care that can be easily added to your daily routine. That’s why we keep ZeroT very cost-effective.”

To learn more about or support ZeroT Cap, visit its Indiegogo page

Hair Growth Cap ZeroT Is On Its Way to Raise Six Figures on Indiegogo

Source

Recent Posts

Hair Growth Cap ZeroT

Hair Growth Cap ZeroT

Hair Growth Cap ZeroT Is On Its Way to Raise Six Figures on Indiegogo

ZeroT Cap is ZEROi LAB’s third crowdfunding hat product and is their most innovative yet. It is a Low-level Light Therapy (LLLT) cap that makes professional hair treatment accessible to the average consumer. It has received a warm welcome from the global crowdfunding community for being a one-of-a-kind product offered at an affordable price. This is also ZEROi LAB’s third crowdfunding project

After reaching its Indiegogo funding goal in just 12 hours, the product went on to be featured as a Team Favorite by Indiegogo’s team as well as featured by many backer-community platforms like Kickbooster and BackerLand. With the campaign nearing $50,000 at its halfway point, it’s well on pace to reach six figures by the end.

ZeroT has three 20-minute modes of care—red light, blue light, and dual mode. The red light (650nm) reaches deep into the scalp to stimulate nutrient flow to the hair follicles while blue light (405nm) eliminates unnecessary oils and germs from the scalp’s surface. Dual mode allows total care with ten minutes of red light followed by ten minutes of blue light.

ZeroT also has three intensity levels, totalling at nine treatment options.

Despite the cap being wireless and flexible, making it more convenient to wear on the go, it is listed at a fraction of the price of other hair growth helmets on the market. Most caps of similar hair treatment are priced at $1,000 while ZeroT Cap’s Early Bird reward price is $140.

“In order to see an actual difference in your hair, you need to uphold a regular care routine,” said ZEROi LAB CEO Taekyeong Oh. “The goal of ZeroT Cap is to present an affordable and convenient solution to hair care that can be easily added to your daily routine. That’s why we keep ZeroT very cost-effective.”

To learn more about or support ZeroT Cap, visit its Indiegogo page

Hair Growth Cap ZeroT Is On Its Way to Raise Six Figures on Indiegogo

Source

Recent Posts

Phase 2a trial evaluating CTP-543

Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata. The Company expects to report topline results from THRIVE-AA1 in 2022. A second Phase 3 trial, THRIVE-AA2, is expected to begin in the first half of 2021.

“Based on the results from our Phase 2 program, we believe CTP-543 has the potential to offer patients a best-in-class treatment for moderate to severe alopecia areata,” said James V. Cassella, Ph.D., Chief Development Officer, Concert Pharmaceuticals. “We are fully committed to advancing CTP-543 with its Breakthrough Therapy designation in order to make a meaningful difference in the lives of individuals impacted by alopecia areata.”

The initiation of THRIVE-AA1 follows an end-of-phase 2 meeting where Concert discussed key aspects of its Phase 3 program and registration strategy with the U.S. Food and Drug Administration (FDA). The end-of-phase 2 meetings with the FDA was held following positive results from a dose-ranging Phase 2 trial of CTP-543 in patients with moderate to severe alopecia areata. Under current timelines, the Company believes that positive results from two Phase 3 trials could serve as the basis for submitting a New Drug Application in early 2023 for CTP-543 for the treatment of moderate to severe alopecia areata in adult patients.

“There are millions of people around the world affected by and living with alopecia areata,” said Andy Bryant, Acting Chief Executive Officer of the National Alopecia Areata Foundation. “We’re encouraged by CTP-543’s potential to be one of the first FDA-approved medicines to treat alopecia areata.”

About the THRIVE-AA1 Study

THRIVE-AA1 (NCT04518995) is a randomized, double-blind, placebo-controlled clinical trial in adult patients with moderate to severe alopecia areata at sites in the U.S., Canada and Europe evaluating the regrowth of scalp hair after 24 weeks of dosing using the Severity of Alopecia Tool (SALT). Key aspects of THRIVE-AA1 include:

  • Patient characteristics: adults age 18-65 years with ≥ 50% hair loss are eligible for the study;
  • Expected enrollment size: approximately 700 patients;
  • Dosing: 8 mg twice-daily or 12 mg twice-daily of CTP-543 or placebo for 24 weeks; and
  • Primary endpoint: Percent of patients achieving a SALT score ≤ 20 at Week 24.

For more information about the THRIVE-AA1 study, please visit https://clinicaltrials.gov/ct2/show/NCT04518995.

About CTP-543 and Alopecia Areata

CTP-543 is an oral selective inhibitor of Janus kinases JAK1 and JAK2. The FDA has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body. Alopecia areata may affect up to 700,000 Americans at any given time1.

The scalp is the most commonly affected area, but any hair-bearing site can be affected alone or together with the scalp. The onset of the disease can occur throughout life and affects both women and men. Alopecia areata can be associated with serious psychological consequences, including anxiety and depression. There are currently no drugs approved by the FDA for the treatment of alopecia areata.

The FDA selected alopecia areata as one of eight new disease areas that it focused on under its Patient-Focused Drug Development Initiative (PFDDI) in 2016-2017.

The goal of the PFDDI is to bring patient perspectives into an earlier stage of product development. Following the FDA’s Patient-Focused Drug Development meeting held in September 2017 on alopecia areata, the FDA summarized the input shared by patients and patient representatives in a Voice of the Patient report.

Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Source

Recent Posts

Alopecia Treatment Market

Alopecia Market Size

Alopecia Market Size, Share, Trends, Growth, Forecast Analysis Report 2019 By Product, By Application, By Segment, By Region – Global Forecast To 2025

Up Market Research offers a latest published report on “Global Global Alopecia Market Research Report 2019 Market Research Report 2019” delivering key insights and providing a competitive advantage to clients through a detailed report. The report highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Global Alopecia Market Research Report 2019 Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Global Alopecia Market Research Report 2019 Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2019 – 2026.

The report for Global Alopecia Market Research Report 2019 Market analysis & forecast 2019 – 2026 is segmented into Product Segment, Application Segment & Major players.

Region-wise Analysis Global Alopecia Market Research Report 2019 Market covers:

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

The Global Alopecia Market Research Report 2019 Market Report can be segmented into Product Types and Applications.

The Report Covers In-Depth Analysis As Follows:

• Chapter 1 Overview of Global Alopecia Market Research Report 2019 Market
• Chapter 2 Global Market Status and Forecast by Regions
• Chapter 3 Global Market Status and Forecast by Types
• Chapter 4 Global Market Status and Forecast by Downstream Industry
• Chapter 5 Market Driving Factor Analysis of Global Alopecia Market Research Report 2019 Market
• Chapter 6 Global Alopecia Market Research Report 2019 Market Competition Status by Major Manufacturers
• Chapter 7 Global Alopecia Market Research Report 2019 Market Major Manufacturers Introduction and Market Data
• Chapter 8 Upstream and Downstream Market Analysis of Global Alopecia Market Research Report 2019 Market
• Chapter 9 Cost and Gross Margin Analysis of Global Alopecia Market Research Report 2019 Market
• Chapter 10 Marketing Status Analysis of Global Alopecia Market Research Report 2019 Market
• Chapter 11 Report Conclusion
• Chapter 12 Research Methodology and Reference

“Global Alopecia Market Research Report 2019 Market Analysis and Forecast 2019 – 2026” report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market-driven results deriving feasibility studies for client needs. UpMarketResearch ensures qualified and verifiable aspects of market data operating in the real-time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real-time scenario.

Global Alopecia Market Research Report 2019 Market: Key Stakeholders:

• Manufacturers
• Distributors/Traders/Wholesalers
• Subcomponent Manufacturers
• Industry Association
• Downstream Vendors

In this study, the years considered to estimate the market size of the Global Alopecia Market Research Report 2019 Market are as follows:

• History Year: 2013-2018
• Base Year: 2018
• Estimated Year: 2019
• Forecast Year 2019 to 2026

Key Reasons to Purchase:

• To gain insightful analyses of the market and have a comprehensive understanding of the “Global Alopecia Market Research Report 2019 Market” and its commercial landscape.
• Learn about the market strategies that are being adopted by your competitors and leading organizations.
• To understand the future outlook and prospects for Global Alopecia Market Research Report 2019 Market analysis and forecast 2019 – 2026.

Customization of the Report:

Up Market Research provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

You can also ask for region wise market research report, as below:

• Global Alopecia Market Research Report 2019 Market – Global Market Status & Trend Report 2013- 2026 Top 20 Countries Data
• Global Alopecia Market Research Report 2019 Market – North America Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – South America Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – Europe Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – EMEA Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – Asia Pacific Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – China Market Status and Trend Report 2013- 2026
• Global Alopecia Market Research Report 2019 Market – India Market Status and Trend Report 2013- 2026

Alopecia Market Size, Share, Trends, Growth, Forecast Analysis Report 2019 By Product, By Application, By Segment, By Region – Global Forecast To 2025

Recent Posts

CTP-543 Phase 3 Trials in Alopecia Areata

CTP-543 Alopecia Areata

Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress

Concert Pharmaceuticals today announced that it will present clinical data on CTP-543 for the treatment of alopecia areata as a late-breaker oral presentation at the 29th European Academy of Dermatology and Venereology (EADV) Virtual Congress. The meeting will be held virtually October 29-31, 2020.

The oral presentation will highlight new data from an ongoing open-label extension study evaluating long-term safety and treatment effects of CTP-543 in patients with moderate to severe alopecia areata.

The details of the presentation are as follows:

  • Title: Initial Results from a Long-Term, Open-Label Extension Study with CTP-543, an Oral Janus Kinase Inhibitor, in Patients with Moderate to Severe Alopecia Areata
  • Date and Time: Thursday, October 29, 2020, 3:00 – 3:15 pm Central European Time
  • Session: D1T03.3C: Late-Breaking News Session
  • Location: EADV Virtual Meeting. Registration is required to participate: https://eadvvirtualcongress.org/registration/

About CTP-543 and Alopecia Areata

CTP-543 is an oral selective inhibitor of Janus kinases JAK1 and JAK2. The U.S. Food and Drug Administration (FDA) has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

The Company expects to begin Phase 3 evaluation of CTP-543 in the fourth quarter of 2020. Additional information on the upcoming trial is available on www.clinicaltrials.gov.

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body. Alopecia areata may affect up to 700,000 Americans at any given time1.

The scalp is the most commonly affected area, but any hair-bearing site can be affected alone or together with the scalp. Onset of the disease can occur throughout life and affects both women and men. Alopecia areata can be associated with serious psychological consequences, including anxiety and depression. There are currently no drugs approved by the FDA for the treatment of alopecia areata.

The FDA selected alopecia areata as one of eight new disease areas that it focused on under its Patient-Focused Drug Development Initiative (PFDDI) in 2016-2017. The goal of the PFDDI is to bring patient perspectives into an earlier stage of product development.

Following the FDA’s Patient-Focused Drug Development meeting held in September 2017 on alopecia areata, the FDA summarized the input shared by patients and patient representatives in a Voice of the Patient report. Additional information on the PFDDI is available online.

About Concert

Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to treat serious diseases and address unmet patient needs.

The Company’s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert’s pipeline of innovative medicines targets autoimmune diseases and central nervous systems (CNS) disorders.

For more information please visit www.concertpharma.com

1 Benigno M. Clinical, Cosmetic and Investigational Dermatology 2020

Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress

Source

Previous Post

PRP Workshop To Enhance Hair Restoration

Stem Cell and Platelet Rich Plasma

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market report focused on the comprehensive analysis of current and future prospects of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry.

This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors.

An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market has been done in order to calculate the growth rates for each segment and sub-segments.

Top Key Vendors of this Market are:

Orange County Hair Restoration Center, Colorado Surgical Center& Hair Institute, Evolution Hair Loss Institute, Hair Sciences Center of Colorado, Hair Transplant Institute of Miami, Anderson Center for Hair, Virginia Surgical Center, Savola Aesthetic Dermatology Center

Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market’s trajectory between forecast periods.

The report provides insights on the following pointers:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. It focuses on the major points, which are necessary to make positive impacts on market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

  • It offers an analysis of changing competitive scenario.
  • For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
  • It offers a seven-year assessment of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.
  • It helps in understanding the major key product segments.
  • Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
  • It offers the regional analysis of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market along with business profiles of several stakeholders.
  • It offers massive data about trending factors that will influence the progress of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.

Table of Contents

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Report 2020 – 2026

Chapter 1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecast

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Source

Previous Post

Thinning Hair and Hair Loss Product Market

Trial for Androgenic Alopecia in Men

Trial for Androgenic Alopecia in Men

The global hair transplant market size was USD 5.94 billion in 2018 and is projected to reach USD 43.13 billion by 2026, exhibiting a CAGR of 28.1% during the forecast period.

We are in process of revamping Hair Transplant Market with respect to COVID-19 Impact.

The hair transplant industry has rapidly undergone a pioneering transformation over the years. From the traditional Follicular Unit Transplantation (FUT) to Follicular Unit Extraction (FUE), the market has witnessed several technological advancements. Yet, it is still controversial for the physicians which transplantation method is the best so far.

Moreover, non-surgical procedures are also coming up with numerous advancements in medical devices for hair loss treatment. Pharmaceutical companies are focusing on R&D to launch an effective drug to assist hair loss.

As alopecia (commonly known as baldness) is very common among the populations in Asia Pacific and the Middle East & Africa, the hair restoration market is expected to exhibit an upsurging demand during the forecast period. In addition, growing investments in integrating robotics with transplantation technologies would also contribute to the faster growth of the market in the coming years.

Technological Advancements in Robotic Hair Transplantation to Propel Market Growth

Since the introduction of robotic hair transplantation, there have been continuous improvements in technology. Transplantation centres and top clinics are putting efforts into increasing the sophistication of the technique to yield effective treatment outputs. These efforts are facilitating market growth to a greater extent.

For example, recently in 2018, Restoration Robotics launched a 9x ARTAS robotic transplant system. The 9x ARTAS is the fastest and most accurate than the previous ARTAS version having better functionality. It has also been coupled with artificial intelligence (AI) to improve productivity and enhance system capabilities. Such technological advancements in the hair restoration industry would help grab a greater number of patients and yield better revenue during the forecast period.

Rapid Expansion of Patient Pool with Higher Disposable Income to Proliferate Market Potential

Due to the rapid advancements in the hair transplantation market, nearly all men and women who have alopecia can be successfully treated with these transplantation techniques. This achievement of the market has led to an increase in the patient population.

In the current scenario of the developing economies due to rising disposable income, men and women are largely spending on aesthetic procedures. This has led to the growth of the hair restoration market over the years.

According to the American Society of Aesthetic Plastic Surgery in 2016, Americans spent approximately USD 15 billion on surgical as well as non-surgical aesthetic procedures. Furthermore, based on the survey of Kaya Limited, there is a strong potential market in India owing to its rising disposable income and aspirational middle-class population.

Thus, considering the above points, it is anticipated that the hair restoration market has proliferative growth during the forecast period.

Increasing Prevalence of Androgenic Alopecia to Fuel Market Growth

Hair transplantation is the most common surgery performed in men worldwide. Androgenic alopecia is the term used for hair loss in men. According to the International Society of Hair Restoration Surgery (ISHRS), every year, approximately 35 million men in the U.S. are affected by male pattern baldness.

This increasing prevalence is likely to captivate patients towards hair restoration techniques and treatment options. Additionally, the launch of novel techniques and effective products are also expected to magnetize the patient population towards the hair transplant market during the forecast period. According to ISHRS, owing to the rising prevalence rates of alopecia, hair restoration procedures have been increased by 60% since 2014.

Out of the total surgeries performed, 87% of the patients are men. Therefore, increasing patient population and prevalence of androgenic alopecia are anticipated to elicit tremendous growth of the market during the forecast period.

High Surgical Procedure Cost to Limit the Growth of the Global Market

Even though transplantation technology has proved its effectiveness in restoring hair, the high cost of the procedure is likely to restrain the market growth. The transplantation procedure cost varies depending on the type of surgical technique preferred.

For instance, according to a study conducted by Robotics, average transplantation cost in the U.S. is around $16,000 and is highest among the other countries. Additionally, the average spending in developing countries such as India is around $3,000. Thus, the high procedure cost is unaffordable by the middle-income population of the countries and will limit the adoption of surgical procedures.

Higher Sales of Non-Surgical Hair Transplant Products to Lead Dominance

Based on type, the market is segmented into surgical and non-surgical. The non-surgical segment dominated the global market in terms of value and market share in 2018. The non-surgical restoration procedure is more advantageous as compared to that of the surgical procedure owing to its lesser side effects and instant results.

Due to such advantages, people are more attracted towards non-surgical hair transplantation. For instance, according to a survey conducted by the International Society of Hair Restoration Surgery (ISHRS), worldwide 1,241,764 patients for the non-surgical procedure were recorded in 2017. The sales of medications, devices to combat hair loss, and adoption of non-surgical techniques had led to the dominance of the segment in 2018.

On the flip side, though the surgical procedure segment had a lower market share in 2018, it is anticipated to gain traction during the forecast period. The segmental rise is attributable to the effectiveness of the surgical procedure. This segment is anticipated to have the highest CAGR and mark an exponential growth during the forecast period.

Adoption of Hair Transplants by Males to Aid Greater Market Share

Based on gender, the market is classified into male and female. The male segment dominated the global market in 2018. This dominance is attributed to the increasing number of surgeries undertaken by males all over the globe. The adoption of surgeries by the male segment of the population is higher owing to the occurrence of alopecia in 60% of the male than the female population.

A similar scenario is observed for the non-surgical procedures as well. For example, according to the data recorded by ISHRS in 2017, 85.7% of the male patients underwent surgical transplantation while 61.8% of the male patients underwent non-surgical procedures. The rising prevalence of alopecia in males is anticipated to mark the highest CAGR for the male segment during the forecast period.

Moreover, the female segment has recorded a lower hair transplant market share. Steady growth is anticipated during the forecast period owing to the lesser preference of females for transplantation of hair.

Growing Surgeries in Hospitals and Specialty Clinics to Aid Higher Market Value

By end-user, the global market is classified into hospitals & clinics and hair transplant centers. In 2018, the hospitals & clinics segment held the leading position in the market. The dominance is attributed to factors such as higher investments in infrastructure management and growing demand for surgical procedures by the patient population at hospitals and clinics. The hospitals and clinics have a well-established medical infrastructure and thus are of greater preference for the patient population.

The newly launched systems are adopted and installed by the hospitals and clinics in a short duration due to the availability of adequate funds. For instance, the popular ARTAS system by Restoration Robotics was sold in more than 37 countries globally to different hospitals and physicians.

On the other hand, these transplant centers segment is anticipated to showcase a slower growth during the forecast period owing to the generation of lower revenue by the centers. Also, a lack of awareness about the hair transplantation centers in the patient population would hinder the growth.

On the geographical front, the global market was dominated by Asia Pacific in 2018 in terms of market share and market value. The hair transplant market in Asia Pacific was valued at USD 1.88 billion in 2018. The primary factor responsible for the leading position is the highest number of transplantation surgeries of hair performed in the region. According to several research studies conducted by researchers, the populations in Asia Pacific have higher prevalence and chances of alopecia.

This has made the region a potential market for the investors. Additionally, the surgeries performed in the region have led to a generation of higher revenue leading to its dominance. Moreover, the establishment of hair transplant facilities in the region, coupled with higher investments in the advancements of the transplantation systems is contributing to the regional growth of Asia Pacific. Thus, the above factors are responsible to boost the region during the forecast period. The Middle East & Africa holds the second position in the market owing to the availability of the hair transplantation procedures at a lower value. This has led to the adoption of surgical procedures by the MEA population. However, the other factor contributing to the MEA market growth is the growing popularity of hair transplant surgery in Turkey.

On the other hand, North America and Europe are likely to exhibit a considerably lower market growth owing to a lower prevalence of alopecia in the countries and lesser adoption of these transplantation techniques.

Continuous Development of the Hair Transplant Systems Has Led Venus Concept a Leader

The global hair transplant market is fragmented into companies ranging from start-ups to well-established leaders. These market players are continuously focused on developing innovative products to achieve effective transplant procedures and positive outcomes.

Venus Concept has surpassed the other players through rigorous developments and launching of surgical as well as non-surgical treatment products. ARTAS iX robotic system has become one of the most demanding systems worldwide. This system helps to assist physicians in identifying and extracting hair follicular units from the scalp of the alopecia patients. Venus Concept after merging with Restoration Robotics Inc. brought this ARTAS system and has leveraged its potential in the hair restoration market.

Trial for Androgenic Alopecia in Men

Source

Previous Post

Alopecia Treatment Market

Global Alopecia Market

Global Alopecia Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025

Eon Market Research has added a report titled “Global Alopecia (Hair Loss Treatment) Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025”. The report will include the impact of COVID 19 and its impact on the growth of this industry during the forecast period.

The Alopecia (Hair Loss Treatment) market report offers the growth scenarios present globally as well as revenues of the overall market. The Global Alopecia (Hair Loss Treatment) market report thoroughly discusses robust growth prospects and prominent strategies implicated by several key players operating in the global market, which are likely to benefit the market growth and grab a leading position in terms of revenue in the Alopecia (Hair Loss Treatment) market.

In this report, the global Alopecia (Hair Loss Treatment) market is estimated at USD XX million in 2020 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2020 and 2025.

Geographically, this report is segmented into various key Regions

North America
Europe
China
Japan
Southeast Asia
India

Global Alopecia (Hair Loss Treatment) market competition

Shiseido
Rohto
Unilever
Taisho
Angfa
LOreal
Kaminomoto
Merck
Yanagiya Honten
Amorepacific
Procter and Gamble
Himalaya
Gerolymatos International
Merz Pharma
Leader Teck
Vasu Healthcare
VLCC
Ales Group
Shanxi Ante
Wansheng Pharmaceutical
Advanced Skin and Hair
Humanwell Healthcare
Topfond
Lifes2good
Bawang
YNK Pharmaceutical
Apollo
Jingxiutang
Rogaine
Marico

Based on product

Shampoos and Conditioners
Medicine Product

Based on the end users/applications

Men
Women

Global Alopecia Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025

Source

Previous Post

Alopecia Treatment Market

Global Alopecia Market Insights

Global Alopecia Market Insights and Forecast to 2026

Alopecia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alopecia market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alopecia market is segmented into

Oral treatment
Topical treatment
Other treatment

Segment by Application, the Alopecia market is segmented into

Male
Female

Regional and Country-level Analysis

The Alopecia market is analysed and market size information is provided by regions (countries).

The key regions covered in the Alopecia market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Alopecia Market Share Analysis

Alopecia market competitive landscape provides details and data information by players. The report offers a comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.

It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alopecia business, the date to enter into the Alopecia market, Alopecia product introduction, recent developments, etc.

The major vendors covered:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddys Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

Global Alopecia Market Insights and Forecast to 2026

Source

Previous Posts

Alopecia Treatment Market

Androgenic Alopecia Global Clinical Trials

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Summary

The clinical trial report, “Androgenic Alopecia Global Clinical Trials Review, H1, 2020″ provides an overview of Androgenic Alopecia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Androgenic Alopecia.

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

The report also provides prominent drugs for in-progress trials (based on a number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma – Clinical trials database.

Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision-making capabilities and helps to create an effective counter-strategy to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– The report provides top-level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with a reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– The report provides the latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Source

Previous Posts

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Alopecia or hair loss is a chronic dermatology disease in which there is either partial or complete loss of hair from the scalp and other parts of the body.

According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have developed alopecia at some point in time.

A strong family history is one of the main reasons contributing towards pattern baldness or androgenic alopecia in both males and females. As estimated by the International Society of Hair Restoration Surgery (ISHRS), more than 35 million men in the U.S. currently suffer from male pattern baldness. ARTAS robotic hair transplant systems make the hair translation procedure more effective and less painful.

The ARTAS robotic hair transplant system is a computer-assisted equipment use to improve the quality of follicle. It also enhances the quality of the most challenging Follicle Extraction Unit (FUE). Various components of an ARTAS robotic hair transplant system are image-guided robotic arm, small dermal punches and a computer interface.

artas

The robot is guided by a 3-D imaging software and the cameras. The device removes the hair follicle at a rate of 1,000 per hour. The FUE procedure involves removing hair from the donor region of the scalp and then implanting it into the recipient site. The separation of the follicular units from the donor tissue is a tedious, repetitive and labour intensive process. The FUE process requires great precision to prevent damage to follicular units.

The ARTAS robotic hair transplant system has significantly increased the accuracy of the FUE procedure. The ARTAS robotic hair transplant system reduces harvesting time and minimizes any damage to hair follicles with its efficacy and great precision. The ARTAS robotic hair transplant system also improves the chances of graft survival. It is also far more comfortable than traditional and more invasive hair restoration processes.

Robotic Hair Transplant System Market: Drivers and Restraints

Increasing prevalence of various dermatological related disorders will drive the robotic hair transplant system market during the forecast period. Unhealthy lifestyle patterns and an increase in stress levels will further contribute towards the growth of hair restoration treatment and robotic hair transplant systems market.

Genetic and other environmental factors increase baldness among men and women. Technologically improved and minimally invasive transplant treatment methods will increase the growth of the robotic hair transplant system market during the forecast period.

High adoption among people of young age to enhance their appearance will further fuel the overall market of robotic hair transplant systems. However, high cost and various side effects associated with the treatment, such as the itchy scalp, hair thinning, etc., might hinder the growth of the robotic hair transplant system market during the forecast period.

Robotic Hair Transplant System Market: Segmentation

The robotic hair transplant system market can be segmented on the basis of end-user and region. Based on end-user, the hair transplant system market is segmented as:

  • Dermatology Clinics
  • Hospitals

Robotic Hair Transplant System Market: Overview

The ARTAS robotic hair transplant system market is growing at a fast pace as these systems are quite efficient and make the entire procedure more comfortable. Higher adoption of robotic hair transplant treatment over traditional, more time-consuming treatments has given a boost to the overall market of ARTAS robotic hair transplant system.

Robotic Hair Transplant System Market: Regional Outlook

Geographically, the global robotic hair transplant system market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America dominates the robotic hair transplant system market due to the rapid technological advancements and better healthcare facilities.

It is followed by Europe because of high adoption among end-users. Asia-Pacific is expected to witness fast expansion in robotic hair transplant system market due to increasing prevalence of skin-related disorders and growth in healthcare infrastructure. Middle East and African regions will witness sluggish growth because of a lack of awareness among people and the high cost of the treatment.

Robotic Hair Transplant System Market: Key Players

Restoration robotics Inc. is the manufacturer of ARTAS robotic hair transplantation systems, which was FDA approved in 2011. Other manufacturers are also focusing on developing other robotic hair transplant systems.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Peru
    • Rest of LATAM
  • Europe
    • EU – 4 (Germany, France, Italy, Spain)
    • UK
    • BENELUX (Belgium, Netherlands, Luxemburg)
    • NORDIC (Norway, Denmark, Iceland, Sweden)
    • Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
    • Rest of Europe
  • CIS & Russia
  • Japan
  • APEJ
    • Greater China
    • India
    • Korea
    • ASEAN Countries
    • Rest of APEJ
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Iran
    • Israel
    • South Africa
  • Rest of MEA

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Source

Previous Posts